Manufacturer
NOVO NORDISK A/S
Contents
Liraglutide
Indication
Adjunct to reduced-calorie diet & increased physical activity for chronic wt management in adult patients w/ initial BMI of ≥30 kg/m2 or ≥27 kg/m2 to <30 kg/m2 in the presence of at least 1 wt-related comorbidity eg, dysglycaemia (pre-diabetes or type 2 DM), HTN, dyslipidaemia or obstructive sleep apnoea.
Instruction
May be taken with or without food.
Drug interaction
Reduced AUC & decreased Cmax of digoxin & lisinopril.
Malaysia
